The TUXEDO-3 trial is the first study to evaluate the intracranial and extracranial efficacy and safety of a novel ...

Patients in a clinical trail of a drug used to treat advanced head and neck cancer lived an average of 2.5 years longer ...

NHS England has announced the roll-out of a new liquid biopsy blood test to help lung cancer patients receive targeted ...

Scientists say these small health issues might be an early sign of lung cancer - As the NHS offers ‘revolutionary’ blood test ...

When cancer is in the lungs, the simulation reveals patients can die from asphyxiation, where there's not enough oxygen ...

GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for ...

Diagnosed with colorectal cancer, Mdm Kris Chow found hope and resilience through the support of her family and medical team ...

A new study employing novel single-cell multimodal data revealed key insights into the tumor microenvironment predictive of NSCLC treatment response.